Tempus AI
This study is a non-interventional, multicenter, multicohort evaluation of participants with cancer who will undergo longitudinal plasma ctDNA biomarker profiling at specific time points in addition to standard of care therapy.
Cancer
| Study Type : | OBSERVATIONAL |
| Estimated Enrollment : | 500 participants |
| Official Title : | TEMPUS ARIES: A Biobank Registry Platform Study in Oncology |
| Actual Study Start Date : | 2024-06-26 |
| Estimated Primary Completion Date : | 2029-06-01 |
| Estimated Study Completion Date : | 2029-06-01 |
Information not available for Arms and Intervention/treatment
| Ages Eligible for Study: | 18 Years to 99 Years |
| Sexes Eligible for Study: | ALL |
| Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
RECRUITING
Eastern CT and Hematology and Oncology Associates
Norwich, Connecticut, United States, 06360
RECRUITING
Hope and Healing Cancer Services
Hinsdale, Illinois, United States, 60521
RECRUITING
Cancer Care Specialists of Illinois
O'Fallon, Illinois, United States, 62269
RECRUITING
Illinois Cancer Care
Peoria, Illinois, United States, 61615
RECRUITING
Lake Regional Health
Osage Beach, Missouri, United States, 65065
RECRUITING
New Jersey Cancer Center
Belleville, New Jersey, United States, 07109
RECRUITING
Cayuga Medical Center
Ithaca, New York, United States, 14850
RECRUITING
Cancer Care Associates of York
York, Pennsylvania, United States, 17403